Description
CJC-1295 is a growth hormone-releasing hormone (GHRH) analog designed to stimulate GH and IGF-1 production through the hypothalamic-pituitary axis. Engineered for extended activity, CJC-1295 enables researchers to explore prolonged GH pulses without frequent dosing windows.
Common areas of investigation include recovery, muscle retention, tissue healing, and metabolic optimization. When paired with secretagogues like Ipamorelin, this peptide is often studied for synergistic effects in GH-focused research protocols.
⚠️ For research use only. Not intended for human or animal use. All claims reference published scientific literature.





